DEVELOPMENT SITE ONLY
Please use current guidelines available on the UHNM intranet for patient treatment
Please use current guidelines available on the UHNM intranet for patient treatment
DEFINITION
Severe deficit
- Serum Mg2+ <0.5 mmol/L
Moderate deficit
- Serum Mg2+ 0.5-0.7 mmol/L
Mild deficit
- Magnesium is largely intracellular so mild deficiency can occur with a normal serum concentration, but urine excretion will be reduced:
- urine Mg2+/urine creatinine <0.1 = deficiency; <0.05 = severe deficiency, except if secondary to renal loss - see Investigations
COMMON CAUSES
Gastrointestinal loss
- Diarrhoea
- Stoma
- Fistula
- Malabsorption states
- Proton pump inhibitors (PPIs)
Renal loss
- Tubular damage
- Genetic syndromes (e.g. Gitelman's syndrome)
- Chronic acidosis
- Phosphate or potassium depletion
- Hypoparathyroidism
- Drug-induced (e.g. loop and thiazide diuretics, aminoglycosides, ciclosporin, cisplatin)
Other
- Alcoholism
- Insulin administration
- Critical illness
SYMPTOMS AND SIGNS
- Non-specific and often attributed to hypocalcaemia or hypokalaemia
Musculoskeletal
- Muscle twitching
- Tremor
- Tetany
- Cramps
CNS
- Apathy
- Depression
- Hallucinations
- Agitation
- Confusion
- Fits
Cardiovascular
- Tachycardia
- Hypertension
- Arrhythmias (e.g. torsade de pointes)
- Digoxin toxicity
INVESTIGATIONS
- Cause usually apparent from clinical picture - investigation necessary only if not obvious
- Check U&E, bone profile and PTH as Mg2+ deficiency associated with hypocalcaemia and hypokalaemia
- Calculate fractional excretion of Mg2+ in a random urine sample from:
Urine Mg2+x serum creatinine x 100 |
Serum Mg2+ x urine creatinine x 0.7 |
(units for each of urine and serum must be the same)
- fractional excretion of Mg2+ >3% indicates renal loss. See above for causes
- If hypocalcaemia or hyperphosphataemia present, check plasma parathyroid hormone
IMMEDIATE TREATMENT
Severe deficiency (Serum Mg2+ <0.5 mmol/L), intractable loss or symptoms of hypocalcaemia or hypokalaemia
- IV route: Magnesium sulphate 5 g (20 mmol in 10 mL) into 250 mL glucose 5% (or sodium chloride 0.9%) over 4 hr
- if given peripherally, monitor insertion site closely for phlebitis using a recognised infusion phlebitis scoring tool
- through a central line in critical care only, minimum dilution is 100 mL
Life-threatening features
- Cardiac monitoring with resuscitation facilities available
- Give a bolus of 4g (16mmol) in 20mL sodium chloride 0.9% over 30 min
Mild to Moderate deficiency (serum Mg2+ >0.5 mmol/L)
- Oral magnesium aspartate 243 mg powder for oral solution. Dose: 1-2 sachets (equivalent to 243-486 mg magnesium or 10-20 mmol magnesium) dissolved in 50-200 mL water, tea or orange juice, daily
- if tolerance to oral intake limited by diarrhoea, reduce dose to maximum tolerated
- Stop PPIs if possible, substituting H2 antagonists if necessary
MONITORING
- Leave at least 2 hr after end of infusion before checking serum Mg2+
- if still <0.5 mmol/L, repeat dose as required by repeated serum Mg2+ level and symptoms
- otherwise, check again after 24 hr
- Toxicity rare if renal function normal
- Clinical signs of overdose:
- loss of tendon reflexes (>5 mmol/L)
- hypotension
- bradycardia
- respiratory depression (>7.5 mmol/L)